Related Experiment Video
Updated: Mar 24, 2026

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
Published on: January 7, 2015
Colchicine in cardiovascular disease: an ancient drug with modern tricks
David C Tong1, Andrew M Wilson2, Jamie Layland3
1Department of Cardiology, St Vincent's Hospital, Fitzroy, Victoria, Australia Department of Cardiology, Peninsula Health, Frankston, Victoria, Australia.
Abstract:
From the dark history of being a poison and purgative, colchicine has risen to become one of the few irrefutable positives in the history of pharmacology in the management of myriad inflammatory conditions. Colchicine exerts its action through binding to tubulin, which in turn affects several cellular processes and pathways modulating the inflammatory response. Despite narrow therapeutic-toxicity window and the most common complaint of gastrointestinal upset, its list of medicinal use is expanding in recent years as we continue to unravel the mystery of this ancient remedy. In this review, we summarise the history of colchicine use, discuss its pharmacokinetics and mechanism of actions, and examine the most up-to-date evidence of colchicine in the treatment of various cardiac conditions with a focus on cardiovascular disease.
Related Concept Videos
Drugs that Destabilize Microtubules
Rheumatic Heart Disease III: Medical Management
Cardiovascular Drugs: Classification based on Therapeutic Indications
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Coronary Artery Disease V: Interprofessional Care
Heart Failure Drugs: Inotropic Agents

